Dose Selection for Fremanezumab (AJOVY) Phase 3 Pediatric Migraine Studies Using Pharmacokinetic Data from a Pediatric Phase 1 Study and a Population Pharmacokinetic Modeling and Simulation Approach.

Orit Cohen-Barak,Andrijana Radivojevic,Aksana Jones,Jill Fiedler-Kelly,Michael Gillespie, Michael Brennan,Dikla Gutman,Michele Rasamoelisolo,Hussein Hallak,Pippa Loupe,Yoel Kessler,Xiaoping Ning,Micha Levi,Andrew H. Ahn,Laura Rabinovich-Guilatt

Cephalalgia（2021）

引用 6|浏览30
暂无评分
关键词
Fremanezumab,migraine,calcitonin-gene-related peptide,CGRP,pediatric dosing,population pharmacokinetics
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要